Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

This article has been cited by the following article(s):

GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis

Sébastien Pomel, Wei Mao, Tâp Ha-Duong, Christian Cavé and Philippe M. Loiseau
Frontiers in Cellular and Infection Microbiology 9 (2019)
DOI: 10.3389/fcimb.2019.00186
See this article

test

F1000Research 5 68 (2017)
DOI: 10.12688/f1000research.6357.2
See this article

Investigational drugs for visceral leishmaniasis

Shyam Sundar and Jaya Chakravarty
Expert Opinion on Investigational Drugs 24 (1) 43 (2015)
DOI: 10.1517/13543784.2014.954035
See this article

Recent synthetic efforts in the preparation of 2-(3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agents

Dayana Orozco, Vladimir V. Kouznetsov, Armando Bermúdez, et al.
RSC Advances 10 (9) 4876 (2020)
DOI: 10.1039/C9RA09905K
See this article

In vitro and in vivo antileishmanial properties of a 2- n -propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route

Kaluvu Balaraman, Nashira Campos Vieira, Fathi Moussa, et al.
Biomedicine & Pharmacotherapy 76 127 (2015)
DOI: 10.1016/j.biopha.2015.10.028
See this article

New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani

Vasanthan Ravichandran, Nalia Mekarnia, Sébastien Pomel, et al.
Regenerative Engineering and Translational Medicine 4 (1) 11 (2018)
DOI: 10.1007/s40883-018-0045-3
See this article

Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases

Vladimir V. Kouznetsov, Carlos M. Meléndez Gómez, José Luis Valencia Peña and Leonor Y. Vargas-Méndez
Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases 87 (2019)
DOI: 10.1016/B978-0-12-815723-7.00004-3
See this article

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, et al.
F1000Research 4 34 (2015)
DOI: 10.12688/f1000research.6110.2
See this article

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, et al.
F1000Research 4 34 (2015)
DOI: 10.12688/f1000research.6110.1
See this article

Insights into the current status of privileged N-heterocycles as antileishmanial agents

Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, et al.
Molecular Diversity 24 (2) 525 (2020)
DOI: 10.1007/s11030-019-09953-4
See this article